Join to view full profile
UK Rose St# 800Lexington, KY 40536
Phone+1 859-257-1000
Fax+1 859-323-2039
Dr. DiPaola is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1991 - 1994
Duke University HospitalResidency, Internal Medicine, 1988 - 1991
University of Utah School of MedicineClass of 1988
Certifications & Licensure
KY State Medical License 2016 - 2027
NJ State Medical License 1994 - 2017
PA State Medical License 1991 - 1994
NC State Medical License 1990 - 1992
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA oncology information system (for Medical Oncology), Varian Medical Systems, 2013-2014, 2016
- CMS Meaningful Use Stage 2 Certification ARIA Oncology Information System (for Medical Oncology), Varian Medical Systems, 2013-2014, 2016
- CMS Meaningful Use Stage 2 Certification Patient Engagement Portal, Navigating Cancer, Inc., 2013-2014, 2016
Clinical Trials
- Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy Start of enrollment: 2001 Apr 05
- Ixabepilone in Treating Patients With Metastatic Prostate Cancer
- Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia
Publications & Presentations
PubMed
- 1 citationsGenetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial.Daniel Sentana-Lledo, Xiangying Chu, Charles J Ryan, Arjun Gupta, Christopher J Sweeney
European Urology Oncology. 2026-04-01 - 8 citationsPatient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED).Daniel Sentana-Lledo, Xiangying Chu, David F Jarrard, Michael A Carducci, Robert S DiPaola
European Urology Oncology. 2025-02-01 - 8 citationsRandomized, Double-Blind Phase III Study of Pazopanib Versus Placebo in Patients With Metastatic Renal Cell Carcinoma Who Have No Evidence of Disease After Metastasect...Leonard J Appleman, Se Eun Kim, Wayne B Harris, Sumanta K Pal, Michael R Pins
Journal of Clinical Oncology. 2024-06-10
Press Mentions
Breathing Easier — Kentucky’s New Era in Lung Care BeginsJanuary 22nd, 2025- Kentucky Is Facing a Health Care Shortage. UK’s $2B Plan Hopes To Fill the GapApril 27th, 2023
- $1.6M Gift to Markey Will Establish Endowed Chair in Gynecologic OncologyFebruary 6th, 2023
Grant Support
- Early Clinical Trials Of New Anti-Cancer Agents With Phase I Emphasis (U01)National Cancer Institute2008–2012
- Cancer Center Support GrantNational Cancer Institute2008–2012
- Retinoid, Interferon And Taxol Effects In Breast CancerNational Cancer Institute1998–1999
- To Abrogate BCL-2 Mediated Resist In Prostate CancerNational Cancer Institute1997–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
